SEARCH

SEARCH BY CITATION

References

  • 1
    Schulze A. Creatine deficiency syndromes. Mol Cell Biochem 2003; 244: 14350.
  • 2
    Stöckler S, Holzbach U, Hanefeld F, et al. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res 1994; 36: 409413.
  • 3
    Bianchi MC, Tosetti M, Battini R, et al. Treatment monitoring of brain creatine deficiency syndromes: a 1H- and 31P-MR spectroscopy study. Am J Neuroradiol 2007; 28: 54854.
  • 4
    Mercimek-Mahmutoglu S, Stoeckler-Ipsiroglu S, Adami A, et al. GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis. Neurology 2006; 67: 48084.
  • 5
    Van Der Knaap MS, Verhoeven NM, Maaswinkel-Mooij P, et al. Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect. Ann Neurol 2000; 47: 54043.
  • 6
    Vodopiutz J, Item CB, Häusler M, Korall H, Bodamer OA. Severe speech delay as the presenting symptom of guanidinoacetate methyltransferase deficiency. J Child Neurol 2007; 22: 77374.
  • 7
    Verbruggen KT, Knijff WA, Soorani-Lunsing RJ, et al. Global developmental delay in guanidinoacetate methyltransferase deficiency: differences in formal testing and clinical observation. Eur J Pediatr 2007; 166: 92125.
  • 8
    Gray RG, Preece MA, Green SH, Whitehouse W, Winer J, Green A. Inborn errors of metabolism as a cause of neurological disease in adults: an approach to investigation. J Neurol Neurosurg Psychiatry 2000; 69: 512.
  • 9
    Hiramatsu M. A role for guanidino compounds in the brain. Mol Cell Biochem 2003; 244: 5762.
  • 10
    Schulze A, Ebinger F, Rating D, Mayatepek E. Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 2001; 74: 41319.
  • 11
    Verbruggen KT, Sijens PE, Schulze A, Lunsing RJ, Jakobs C, Salomons GS, Van Spronsen FJ. Successful treatment of a guanidinoacetate methyltransferase deficient patient: findings with relevance to treatment strategy and pathophysiology. Mol Genet Metab 2007; 91: 29496.
  • 12
    Schulze A, Hoffmann GF, Bachert P, et al. Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency. Neurology 2006; 67: 71921.
  • 13
    Caldeira Araujo H, Smit W, Verhoeven NM, et al. Guanidinoacetate methyltransferase deficiency identified in adults and a child with mental retardation. Am J Med Genet A 2006; 133: 12227.
  • 14
    Almeida LS, Verhoeven NM, Roos B, et al. Creatine and guanidinoacetate: diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol Genet Metab 2004; 82: 21419.
  • 15
    Verhoeven NM, Roos B, Struys EA, Salomons GS, Van Der Knaap MS, Jakobs C. Enzyme assay for diagnosis of guanidinoacetate methyltransferase deficiency. Clin Chem 2004; 50: 44143.